India Lymphedema Treatment Market Forecast (2020-2030)
India Lymphedema Treatment Market Forecast (2020-2030), and Country Share, Trend, and Growth Opportunity Analysis Coverage: Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type [Compression Devices and Bandaging, Drug Therapy, Physiological Procedure (Lymphovenous Anastomosis and Vascularized Lymph Node Transfer), Debulking Procedure, and Others], and End User (Hospitals, Clinics, Clinical Research Organizations, and Others))
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Factors such as the prevalence of lymphatic filariasis, adverse effects of cancer treatment, and growing awareness of lymphedema are driving the market growth. However, the high cost of lymphedema treatment is hampering the market growth.
Use of Robotics for Lymphedema Treatment
The recent development of robotic-assisted microsurgery and super microsurgery has raised great expectations to support some of the most demanding microsurgical procedures applied in lymphatic reconstructive surgery to restore lymphatic vascular integrity and treat lymphedema. For instance, in March 2023, a 43-year-old woman in Delhi was successfully treated for lymphedema using a supermicro surgery procedure at BLK-Max Super Speciality Hospital’s Surgical Oncology Department. The patient had undergone breast conservation surgery with axillary lymph node dissection, followed by chemotherapy and radiation. The patient had a speedy recovery and could return to her daily work routine within four weeks of surgery with a full range of motion.
Recent preclinical and clinical studies of independent groups using different robotic systems demonstrate the feasibility of robotic technology to perform super microsurgical procedures successfully. The robotic assistance offers unparalleled precision, refining the surgical techniques and minimizing potential side effects, with clinical outcomes comparable to the traditional techniques. Robotic-assisted super microsurgery enables the performance of this delicate surgery beyond the physical capabilities of human hands, offering unprecedented dexterity, accuracy, and endurance. In addition, robotic systems will make access to the central part of the lymphatic system, e.g., the thoracic duct, more accessible.
The inclusion of artificial intelligence systems in robot-assisted systems promises to bring surgical techniques to a new level. The recording and analyzing of surgical movements used in intelligent robots will result in the development of cognitive skills and a process of “self-learning,” thus leading to semi-automated surgical applications.
Therefore, the use of robotics in the treatment of lymphedema is likely to support the market growth in the future.
India Lymphedema Treatment Market: Segmental Overview
The “India Lymphedema Treatment Market” is segmented based on condition type, treatment type, and end user.
Based on the condition type, the global lymphedema treatment market is segmented into primary lymphedema and secondary lymphedema. The secondary lymphedema segment held the largest share of the market in 2022. The primary lymphedema segment is anticipated to register a higher CAGR during 2022–2030. Secondary lymphedema’s significant share is usually attributed to cancer-related treatment, which is a prominent cause of secondary lymphedema.
Based on treatment type, the global lymphedema treatment market is segmented into compression devices and bandaging, drug therapy, physiological procedure, debulking procedure, and others. The physiological procedures segment is further segmented into lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT). The debulking procedures segment is sub-segmented into liposuction, surgical debulking, and others. The compression devices and bandaging segment held the largest share of the market in 2022. The physiological procedure segment is expected to register the highest CAGR in the market during 2022–2030. This is mainly due to the appropriate treatment procedures performed on lymphedema patients through LVA and VLNT. These two procedures are appropriate treatment options for patients suffering from lymphedema.
Based on end user, the global lymphedema treatment market is segmented into hospitals, clinics, clinical research organizations (CROs), and others. The hospital segment held the largest share of the market in 2022 and the same is anticipated to register the highest CAGR in the market during 2022–2030 due to many lymphedema procedures being performed in the hospitals and the launch of innovative products by prominent players targeting hospitals for maximum utilization. In September 2020, Paul Hartmann partnered with Apollo Hospitals Group in India and West China Hospitals with a foremost focus on the surgery of wound care clinics and ambulances, medical training, and products and services. Such strategic steps allow companies to expand their product portfolio in developed markets. The hospital segment accounts for the maximum share of the overall lymphedema treatment market. This is mainly due to the growing adoption of minimally invasive surgeries in hospitals and the uptake of advanced imaging modalities for treating lymphedema. Additionally, surgeries are performed in hospitals for treating lymphedema. For example, at the University of Michigan, plastic surgeons and occupational therapists work together to determine the optimal treatment program for patients suffering from illness. For instance, the Penn Medicine report states that about 60% of the patients who underwent lymphedema treatment procedures in hospitals revealed clear improvement. Furthermore, favorable reimbursement policies supporting hospital lymphatic treatment support the overall market growth. For example, the growing awareness of lymphedema as an expensive preventable complication following oncology surgery eliminates the barriers between the medical coverage for therapeutic and prophylactic procedures among patients, hospitals, and the healthcare systems.
India Lymphedema Treatment Market: Country Overview
Radiation due to radiotherapy heightens the risk of lymphedema by directly injuring lymphatic vessels with subsequent reduction to the carrying capacity of the lymphatic vessels. As per an article published in the National Center for Biotechnology Information (NCBI), “Cancer incidence estimates for 2022 and projection for 2025: Result from National Cancer Registry Programme, India,” the number of cancer cases in India was estimated to be 1,461,427 in 2022. In India, 1 in 9 people is likely to develop cancer in their lifetime. Lung and breast were the leading cancer sites in males and females, respectively. As per Globocan 2020 report, breast cancer is the most common cancer in India. There were 178,361 (13.5%) cases of breast cancer in India in 2020. This is likely to demand radiotherapy in India. As per the same report, 72,510 (5.5%) new cases of lung cancer, 135,929 (10.3%) cases of lip and oral cavity cancer, 123,907 (9.4%) cases of cervix uteri cancer, 65,358 (4.9%) cases of colorectum cancer, and 748,348 (56.5%) cases of other cancers were reported in India. Therefore, the growing usage of radiotherapy to treat cancer and the high prevalence of cancer are driving the growth of the India lymphedema treatment market.
The prevalence of chronic diseases such as cardiovascular diseases (CVD) and stroke, rising geriatric population, lifestyle diseases, and the high prevalence rate of obesity in India are among the other factors driving the growth of the market. As per the World Heart Federation, CVDs account for 60% of total adult deaths in India. Addiction of smoking tobacco and increase in alcohol consumption are among the factors resulting in CVD-related risks in Indian adults (i.e., nearly 15% of the population). According to the Indian Stroke Association, 1.8 million people suffer from stroke in India annually. Also, awareness about stroke is less, and people living in rural areas are not aware of neurovascular diseases. Lymphedema can also be as a result of heart strain, and this occurs when the heart has to work harder to pump and circulate blood throughout the body, including the affected limb. Therefore, these factors are anticipated to spur the India lymphedema treatment market in this region.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to our new research study on “India Lymphedema Treatment Market Size and Forecast (2020–2030), Country Share, Trend, and Growth Opportunity Analysis – by Condition Type, Treatment Type, and End User,” the market is expected to grow from US$ 0.926 billion in 2022 to US$ 1.511 billion by 2030; it is estimated to record a cagr of 6.3% from 2022 to 2030.
Lymphedema refers to tissue swelling caused by an accumulation of protein-rich fluid, which is drained through the body’s lymphatic system. It most commonly affects the arms or legs but can also occur in the chest wall, abdomen, neck, and genitals. Lymph nodes are an essential part of the lymphatic system. Lymphedema is largely caused due to the consequence of several cancer treatments. These include prostate, head and neck, and pelvic cancers such as those in bladder, testicles, ovaries, uterus, or cervix, along with lymphoma and melanoma. The swelling may occur on the part of the body that is treated. For instance, treating tumors in the belly or pelvis via radiation or surgery may cause swelling in the groin, genitals, belly, and one or both legs. Swelling in the face, eyes, or mouth can be caused by treatment for head & neck cancer.
Various government organizations and companies operating in the lymphedema market constantly focus on strategic developments such as collaborations, expansions, agreements, partnerships, and product launches. These help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. A few of the noteworthy developments in the lymphedema market are mentioned below:
On July 16, 2021, Sakra World Hospital launched a ‘Comprehensive Lymphedema Care Centre’ on the occasion of World Plastic Surgery. This newly launched center will be equipped with the latest technologies in diagnostics and offer treatment by a team of internationally certified lymphedema specialists, including plastic surgeons, physiotherapists, occupational therapists, clinical psychologists, and clinical nutritionists. Sakra Comprehensive Lymphedema Care Centre will offer services such as ICG-based real-time lymphedema scan, lymphovenous bypass surgery (LVA), lymph node transfer surgery, lymphedema reduction surgery and conservative treatment (Lymphedema rehabilitation).
In November 2021, Anatomech, a Pune-based start-up, launched Kue, a brand of compression socks. The sales rose steadily as soon as it was launched, indicating a heavy demand. Anatomech is developing a daily-wear, portable sleeve that enables continuous lymphatic decongestion for 10–12 hours for patients suffering from lymphedema—a surgical consequence that follows mastectomy or other aggressive surgeries.
The socks, which enhance oxygen delivery and muscle recovery while reducing spasms and cramps in the legs, are a part of the wearable technology products that Anatomech has been working on since 2020. In September, Anatomech was one of the runners-up at the Pune round of the TiE Women’s Global Pitch Competition, which featured 58 women-initiated companies.
As per a news published in Open Digest on September 2023, the Institute of Applied Dermatology (IAD) in Kerala is exploring a tie-up with Indian start-ups to make cost-effective compression bandages to make lymphedema and lymphatic filariasis treatment more affordable for millions of patients, which are a key element in treatment. The compression bandages used for the treatment are considerably expensive. India has all the required natural resources, such as latex and cotton, to make compression bandages but still has to depend heavily on global suppliers for quality compression bandages. Thus, IAD is ready to collaborate with tech start-ups for necessary guidance to develop compression bandages.
Such developments in lymphedema treatment by Indian companies are expected to offer lucrative opportunities to the market.
India Lymphedema Treatment Market, By Condition Type
Based on condition type, the global lymphedema treatment market is segmented into primary lymphedema and secondary lymphedema. The secondary lymphedema segment held the largest market share in 2022. The primary lymphedema segment is anticipated to register a higher CAGR during 2022–2030. Secondary lymphedema’s significant market share is usually attributed to cancer-related treatment, which is a prominent cause of secondary lymphedema.
By condition type, the india lymphedema treatment market is expected to be led by the secondary lymphedema segment.
Primary lymphedema is a rare chronic pathology associated with constitutional abnormalities of the lymphatic system. For instance, the Frontiers S.A. report states that primary lymphedema can appear at age 35 and is also referred to as lymphedema tarda. Additionally, the incidence of primary lymphedema is low, affecting 1 in 100,000 people worldwide. Primary lymphedema is also strongly linked to acquired lymphedema and has genetic mutations causing primary lymphedema. For example, breast cancer patients carrying acquired lymphedema have higher genetic variation, called single nucleotide polymorphisms (SNPs), in the same genes causing primary lymphedema. Such factors positively influence the overall growth of the segment during the analysis period.
Essity AB, Lympha Press USA Ltd, AIROS Medical Inc, 3M Co, Bio Compression Systems Inc, Lohmann & Rauscher GmbH & Co KG, Huntleigh Healthcare Ltd, Dynamic Techno Medicals Pvt Ltd, Medi GmbH & Co KG, Datt Mediproducts Pvt Ltd, Smith & Nephew Plc, SIGVARIS Management AG, and Tactile Systems Technology Inc. are among the leading companies operating in India lymphedema treatment market.
Companies operating in the India lymphedema treatment market adopt various organic and inorganic strategies. Growth strategies mainly include product launches and approvals, mergers & acquisitions, collaborations, and partnerships, among the growth strategies witnessed in the India lymphedema treatment market.
A few of the significant developments by key market players is listed below.
1. KOB GmbH launched its two products at MEDICA Trade Fair 2022. With this 2-component system, the company expanded its product portfolio of compression bandages. VisioCompress2 Lite is used when a lower compression pressure is required. Like the proven VisioCompress2 multi-layer system, VisioCompress2 Lite consists of a padding and permanently elastic non-woven bandage.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in India Lymphedema Treatment Market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the India Lymphedema Treatment Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth country market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. India Lymphedema Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 India PEST Analysis
4.2.2 Lymphedema Treatment Algorithm
4.3 Post Cancer Surgery Lymphedema: Diagnosis and Treatment
4.3.1 Post Cancer Surgery Lymphedema: Diagnosis and Treatment
4.3.1.1 Overview
4.3.1.2 Diagnosis
4.3.1.3 Treatment for Lymphedema
4.4 Phlebology Etiology
4.4.1 Treatment Procedures
4.4.1.1 Lifestyle Changes (Weight Loss and Reducing Obesity)
4.4.1.2 Rehabilitation Exercise and Lymphatic Drainage Massage
4.4.1.3 Compression Therapy and Garments
4.4.1.4 Prescribed Drug Therapy
4.5 Lymphedema Etiology
4.5.1 Treatment Procedure
4.5.1.1 Lifestyle Changes (Weight loss and reducing obesity)
4.5.1.2 Rehabilitation Exercise and Lymphatic Drainage Massage
4.5.2 Competitive Landscape
5. India Lymphedema Treatment Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Lymphedema Cases
5.1.2 Growing Awareness of Lymphedema
5.2 Market Restraints
5.2.1 High Cost of Lymphedema Treatment
5.3 Market Opportunities
5.3.1 Rising Product Launches
5.4 Future Trends
5.4.1 Use of Robotics for Lymphedema Treatment
5.5 Impact Analysis
6. India Lymphedema Treatment Market – Revenue and Forecast to 2030
6.1 India Lymphedema Treatment Market Revenue (US$ Mn), 2022 – 2030
6.1.1 India: India Lymphedema Treatment Market, by Condition Type, 2020–2030 (US$ Million)
6.1.2 India: India Lymphedema Treatment Market, by Treatment Type, 2020–2030 (US$ Million)
6.1.3 India: India Lymphedema Treatment Market, by Physiological Procedures, 2020–2030 (US$ Million)
6.1.4 India: India Lymphedema Treatment Market, by End User, 2020–2030 (US$ Million)
7. India Lymphedema Treatment Market – Revenue and Forecast to 2030 – by Condition Type
7.1 Overview
7.2 India Lymphedema Treatment Market Revenue Share, by Condition Type 2022 & 2030 (%)
7.3 Primary Lymphedema
7.3.1 Overview
7.3.2 Primary Lymphedema: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Secondary Lymphedema
7.4.1 Overview
7.4.2 Secondary Lymphedema: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8. India Lymphedema Treatment Market – Revenue and Forecast to 2030 – by Treatment Type
8.1 Overview
8.2 India Lymphedema Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
8.3 Physiological Procedures
8.3.1 Overview
8.3.2 Physiological Procedures: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Vascularised Lymph Node Transfer (VLNT)
8.3.2.1.1 Overview
8.3.2.1.2 Vascularised Lymph Node Transfer (VLNT): India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Lymphovenous Anastomosis (LVA)
8.3.2.2.1 Overview
8.3.2.2.2 Lymphovenous Anastomosis (LVA): India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Compression Devices and Bandaging
8.4.1 Overview
8.4.2 Compression Devices and Bandaging: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Debulking Procedures
8.5.1 Overview
8.5.2 Debulking Procedures: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Drug Therapy
8.6.1 Overview
8.6.2 Drug Therapy: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. India Lymphedema Treatment Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 India Lymphedema Treatment Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Clinical Research Organization (CRO’s)
9.5.1 Overview
9.5.2 Clinical Research Organization (CRO’s): India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10. Company Profiles
10.1 Essity AB
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Lympha Press USA Ltd
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 AIROS Medical Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 3M Co
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Bio Compression Systems Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Lohmann & Rauscher GmbH & Co KG
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Huntleigh Healthcare Ltd
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Dynamic Techno Medicals Pvt Ltd
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Medi GmbH & Co KG
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Datt Mediproducts Pvt Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
10.11 Smith & Nephew Plc
10.11.1 Key Facts
10.11.2 Business Description
10.11.3 Products and Services
10.11.4 Financial Overview
10.11.5 SWOT Analysis
10.11.6 Key Developments
10.12 SIGVARIS Management AG
10.12.1 Key Facts
10.12.2 Business Description
10.12.3 Products and Services
10.12.4 Financial Overview
10.12.5 SWOT Analysis
10.12.6 Key Developments
10.13 Tactile Systems Technology Inc
10.13.1 Key Facts
10.13.2 Business Description
10.13.3 Products and Services
10.13.4 Financial Overview
10.13.5 SWOT Analysis
10.13.6 Key Developments
11. Appendix
11.1 About Us
11.2 Glossary of Terms
LIST OF TABLES
Table 1. India Lymphedema Treatment Market Segmentation
Table 2. India Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2030 (US$ Million)
Table 3. India Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2030 (US$ Million)
Table 4. India Lymphedema Treatment Market, by Physiological Procedures– Revenue and Forecast to 2030 (US$ Million)
Table 5. India Lymphedema Treatment Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 6. Glossary of Terms, India Lymphedema Treatment Market
LIST OF FIGURES
Figure 1. India Lymphedema Treatment Market Segmentation
Figure 2. India – PEST Analysis
Figure 3. Lymphedema Treatment Algorithm
Figure 4. Competitive Landscape (Player Positioning Analysis)
Figure 5. India Lymphedema Treatment Market: Key Industry Dynamics
Figure 6. India Lymphedema Treatment Market: Impact Analysis of Drivers and Restraints
Figure 7. India Lymphedema Treatment Market Revenue (US$ Mn), 2020 – 2030
Figure 8. India Lymphedema Treatment Market Revenue Share, by Condition Type 2022 & 2030 (%)
Figure 9. Primary Lymphedema: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Secondary Lymphedema: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. India Lymphedema Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 12. Physiological Procedures: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Vascularised Lymph Node Transfer (VLNT): India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Lymphovenous Anastomosis (LVA): India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Compression Devices and Bandaging: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Debulking Procedures: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Drug Therapy: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. India Lymphedema Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Hospitals: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Clinics: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: India Lymphedema Treatment Market – Revenue and Forecast to 2030 (US$ Million)
The List of Companies – India Lymphedema Treatment Market
o Essity AB,
o Lympha Press USA Ltd
o AIROS Medical Inc
o 3M Co
o Bio Compression Systems Inc
o Lohmann & Rauscher GmbH & Co KG
o Huntleigh Healthcare Ltd
o Dynamic Techno Medicals Pvt Ltd
o Medi GmbH & Co KG
o Datt Mediproducts Pvt Ltd
o Smith & Nephew Plc
o SIGVARIS Management AG
o Tactile Systems Technology Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.